Dr. Nathan Fujita
Honolulu, Hawaii, 96813, United States
NCT Number: NCT01090635
The purpose of this study is to investigate the performance ability of the UltraSightHD™. The instrument will be assessed on characteristics such as focus quality, ability to image the entire cervix, and illumination. The information gathered from this study will provide data that will be used to determine which settings provide the best imaging outcome for the cervix for a simple screening instrument. Further, this information will serve as the foundation in the development of more advanced follow-on imaging devices.
The primary objectives of this study are to:
* Determine if the light source provides sufficient illumination of the cervix. * Assess focus and overall image quality. * Assess the functionality and ergonomics of the instrument's design.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Honolulu, Hawaii, 96813, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
STI-Medical Systems
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00804466
Cervical Intraepithelial Neoplasia, Female Urogenital Diseases
Ile-Ife, Nigeria
View Trial DetailsNCT01231945
DNA Probes, E6 Protein
Seattle, Washington, United States
View Trial DetailsNCT01014026
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
La Riche, France
View Trial DetailsNCT00989443
Cervix Intraepithelial Neoplasia, Female Urogenital Diseases
Brussels, Belgium
View Trial Details